Patents by Inventor Sergio Pichuantes

Sergio Pichuantes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8475808
    Abstract: Recombinant production of immunogenic West Nile Virus (WNV) proteins is described. These proteins, heterodimers comprising the proteins, fusions thereof, polynucleotides encoding the proteins, and combinations thereof, as well as antibodies produced therefrom, can be used in immunogenic compositions for preventing, treating and diagnosing WNV infection. Also described are highly sensitive ELISA and strip immunoassay methods for detecting the presence of WNV in biological samples.
    Type: Grant
    Filed: May 21, 2004
    Date of Patent: July 2, 2013
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventors: William Andrews, David Chien, Qui-Lim Choo, Stephen Coates, Doris Coit, Charles Harrington, Susan Hilt, Michael Houghton, Angelica Medina-Selby, Sergio Pichuantes, Yiu-Lian Fong
  • Publication number: 20110053140
    Abstract: Novel methods and immunodiagnostic test kits for the detection of hantavirus infection are disclosed. The methods and kits employ combinations of recombinant N and/or G1 antigens from at least six different hantavirus serotypes, including Hantann (HTNV), Puumala (PUUV), Seoul (SEOV), Dobrava (DOBV), Sin Nombre (SNV) and Andes (ANDV). Additional hantavirus antigens from these and other hantavirus types may also be present. The methods provide for highly accurate results and allow the detection of infection so that treatment can be administered and death avoided.
    Type: Application
    Filed: June 17, 2010
    Publication date: March 3, 2011
    Inventors: Steve H. Nguyen, Sergio Pichuantes
  • Patent number: 7771730
    Abstract: Novel methods and immunodiagnostic test kits for the detection of hantavirus infection are disclosed. The methods and kits employ combinations of recombinant N and/or G1 antigens from at least six different hantavirus serotypes, including Hantaan (HTNV), Puumala (PUUV), Seoul (SEOV), Dobrava (DOBV), Sin Nombre (SNV) and Andes (ANDV). Additional hantavirus antigens from these and other hantavirus types may also be present. The methods provide for highly accurate results and allow the detection of infection so that treatment can be administered and death avoided.
    Type: Grant
    Filed: May 24, 2005
    Date of Patent: August 10, 2010
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventors: Steve H. Nguyen, Sergio Pichuantes
  • Publication number: 20080108051
    Abstract: Novel methods and immunodiagnostic test kits for the detection of hantavirus infection are disclosed. The methods and kits employ combinations of recombinant N and/or G1 antigens from at least six different hantavirus serotypes, including Hantaan (HTNV), Puumala (PUUV), Seoul (SEOV), Dobrava (DOBV), Sin Nombre (SNV) and Andes (ANDV). Additional hantavirus antigens from these and other hantavirus types may also be present. The methods provide for highly accurate results and allow the detection of infection so that treatment can be administered and death avoided.
    Type: Application
    Filed: May 24, 2005
    Publication date: May 8, 2008
    Inventors: Steve H. Nguyen, Sergio Pichuantes
  • Publication number: 20070092538
    Abstract: Recombinant production of immunogenic West Nile Virus (WNV) proteins is described. These proteins, heterodimers comprising the proteins, fusions thereof, polynucleotides encoding the proteins, and combinations thereof, as well as antibodies produced therefrom, can be used in immunogenic compositions for preventing, treating and diagnosing WNV infection. Also described are highly sensitive ELISA and strip immunoassay methods for detecting the presence of WNV in biological samples.
    Type: Application
    Filed: May 21, 2004
    Publication date: April 26, 2007
    Inventors: William Andrews, David Chien, Qui-Lim Choo, Stephen Coates, Doris Coit, Charles Harrington, Susan Hilt, Michael Houghton, Angelica Medina-Selby, Sergio Pichuantes
  • Publication number: 20050221300
    Abstract: Human parvovirus B19 primers and probes derived from conserved regions of the parvovirus B19 genome are disclosed. Also disclosed are nucleic acid-based assays using the primers and probes.
    Type: Application
    Filed: May 23, 2005
    Publication date: October 6, 2005
    Applicant: Chiron Corporation
    Inventors: Sergio Pichuantes, Venkatakrishna Shyamala
  • Patent number: 6942965
    Abstract: Hepatitis A virus primers and probes derived from the capsid proteins and junction between the capsid precursor P1 and 2A of the HAV genome are disclosed. Also disclosed are nucleic acid-based assays using the primers and probes, antigen detection of HAV, and immunoassay for detecting the antibodies that bind to HAV.
    Type: Grant
    Filed: October 15, 2002
    Date of Patent: September 13, 2005
    Assignee: Chiron Corporation
    Inventors: Sergio Pichuantes, Steve H. Nguyen
  • Patent number: 6936442
    Abstract: Human parvovirus B19 primers and probes derived from conserved regions of the parvovirus B19 genome are disclosed. Also disclosed are nucleic acid-based assays using the primers and probes.
    Type: Grant
    Filed: June 28, 2002
    Date of Patent: August 30, 2005
    Assignee: Chiron Corporation
    Inventors: Sergio Pichuantes, Venkatakrishna Shyamala
  • Publication number: 20050130135
    Abstract: Hepatitis A virus primers and probes derived from the capsid proteins and junction between the capsid precursor P1 and 2A of the HAV genome are disclosed. Also disclosed are nucleic acid-based assays using the primers and probes, antigen detection of HAV, and immunoassay for detecting the antibodies that bind to HAV.
    Type: Application
    Filed: February 4, 2005
    Publication date: June 16, 2005
    Inventor: Sergio Pichuantes
  • Publication number: 20030170612
    Abstract: Human parvovirus B19 primers and probes derived from conserved regions of the parvovirus B19 genome are disclosed. Also disclosed are nucleic acid-based assays using the primers and probes.
    Type: Application
    Filed: June 28, 2002
    Publication date: September 11, 2003
    Inventors: Sergio Pichuantes, Venkatakrishna Shyamala
  • Publication number: 20030124517
    Abstract: Hepatitis A virus primers and probes derived from the capsid proteins and junction between the capsid precursor P1 and 2A of the HAV genome are disclosed. Also disclosed are nucleic acid-based assays using the primers and probes, antigen detection of HAV, and immunoassay for detecting the antibodies that bind to HAV.
    Type: Application
    Filed: October 15, 2002
    Publication date: July 3, 2003
    Inventor: Sergio Pichuantes